SAMSUNG PHARM. Co., Ltd. (001360.KS)
001360.KS Stock Price Chart
Explore SAMSUNG PHARM. Co., Ltd. interactive price chart. Choose custom timeframes to analyze 001360.KS price movements and trends.
001360.KS Company Profile
Discover essential business fundamentals and corporate details for SAMSUNG PHARM. Co., Ltd. (001360.KS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
4 Jan 2000
Employees
240.00
Website
https://www.sspharm.co.krCEO
Won-Kyu Kim
Description
SAMSUNG PHARM. Co., LTD. manufactures and sells pharmaceutical products in South Korea. It offers prescription medicines, such as anticancer immunotherapy, antipyretic analgestic and antiinflammatory, antiobesity, hypotensive, antiarteriosclerotic, digestive organs, antophlegms, enzymes, ostepoposis, and transfusion agents, as well as skeletal muscle relaxants, anti-spastic, mixed vitamins, antibiotics, and others. The company also provides medicines for digestive system, medicines for liver disorder, medicines for circulation system, cold medicines, nutritional supplements, health tonics, and others, as well as vitamins and energy drinks, and functional foods. The company was founded in 1929 and is based in Hwaseong-si, South Korea.
001360.KS Financial Timeline
Browse a chronological timeline of SAMSUNG PHARM. Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 9 Feb 2026
Upcoming earnings on 12 Nov 2025
Earnings released on 12 Aug 2025
EPS came in at ₩675.44 , while revenue for the quarter reached ₩10.90B .
Earnings released on 15 May 2025
EPS came in at ₩395.75 , while revenue for the quarter reached ₩11.36B .
Earnings released on 10 Feb 2025
EPS came in at -₩184.16 , while revenue for the quarter reached ₩10.47B .
Earnings released on 15 Nov 2024
EPS came in at ₩194.72 , while revenue for the quarter reached ₩11.08B .
Earnings released on 14 Aug 2024
EPS came in at -₩109.18 , while revenue for the quarter reached ₩10.58B .
Earnings released on 16 May 2024
EPS came in at -₩61.35 , while revenue for the quarter reached ₩12.17B .
Earnings released on 13 Mar 2024
EPS came in at -₩163.48 , while revenue for the quarter reached ₩12.02B .
Earnings released on 15 Nov 2023
EPS came in at -₩83.92 , while revenue for the quarter reached ₩11.72B .
Earnings released on 14 Aug 2023
EPS came in at -₩48.40 , while revenue for the quarter reached ₩14.98B .
Earnings released on 15 May 2023
EPS came in at -₩5.24 , while revenue for the quarter reached ₩13.24B .
Earnings released on 8 Mar 2023
EPS came in at -₩235.17 , while revenue for the quarter reached ₩14.12B .
Earnings released on 14 Nov 2022
EPS came in at -₩45.42 , while revenue for the quarter reached ₩13.90B .
Earnings released on 11 Aug 2022
EPS came in at -₩167.86 , while revenue for the quarter reached ₩11.23B .
Earnings released on 12 May 2022
EPS came in at -₩38.63 , while revenue for the quarter reached ₩12.58B .
Earnings released on 17 Mar 2022
EPS came in at -₩199.56 , while revenue for the quarter reached ₩14.03B .
Earnings released on 15 Nov 2021
EPS came in at -₩94.00 , while revenue for the quarter reached ₩16.81B .
Earnings released on 30 Sept 2021
EPS came in at -₩100.00 , while revenue for the quarter reached ₩10.45B .
Earnings released on 31 Mar 2021
EPS came in at -₩218.00 , while revenue for the quarter reached ₩13.61B .
Earnings released on 31 Dec 2020
EPS came in at -₩331.35 , while revenue for the quarter reached ₩6.09B .
Earnings released on 30 Sept 2020
EPS came in at ₩18.00 , while revenue for the quarter reached ₩16.58B .
001360.KS Stock Performance
Access detailed 001360.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.